Molecular Targets to Alleviate Enteric Neuropathy and Gastrointestinal Dysfunction

Area of Science:

• Neurogastroenterology
• Immunology
• Gastroenterology

Background:

• Enteric neuropathy, affecting the enteric nervous system (ENS), causes long-term gastrointestinal dysfunction.
• Damage to the ENS leads to persistent intestinal dysfunction, aberrant immune responses, and epithelial barrier dysregulation.
• ENS damage is linked to disease progression and symptom recurrence, highlighting its role in chronic GI disorders.

Purpose of the Study:

• To develop novel therapeutic strategies for enteric neuropathy in chronic GI disorders.
• To evaluate the anti-inflammatory and neuroprotective effects of new compounds targeting specific molecular pathways.
• To understand the molecular mechanisms of enteric neuropathy and test therapeutic interventions.

Main Methods:

• Ex vivo studies using human tissues to elucidate molecular mechanisms.
• In vivo experiments in preclinical animal models to assess therapeutic efficacy.
• Testing novel compounds and their combinations with existing therapies.

Main Results:

• Demonstrated structural and functional ENS changes leading to persistent intestinal alterations.
• Identified novel compounds with anti-inflammatory and neuroprotective properties.
• Provided data on the efficacy and mechanisms of action of tested therapies in animal models.

Conclusions:

• The enteric nervous system (ENS) is a viable therapeutic target for chronic intestinal dysfunction.
• Novel compounds show potential for treating enteric neuropathy.
• Findings support the development of safe, cost-effective, and efficacious treatments for GI disorders.